Dear Sir:
Studies using dietary conditions with exaggerated nutritional compositions are often used to define the potential for biological responses and to act as starting points for understanding nutritional effects on health. The monkeys in the study consumed 30% more fructose than the unhealthiest humans, with fructose approximating the 95th percentile of total carbohydrate consumption (1, 2). This intake was modeled on the clinical study by Stanhope et al (3), which showed changes in adiposity, plasma lipids, and insulin sensitivity. Monkeys supplemented with fructose at this same amount (4) similarly experienced detrimental changes in these variables. Thus, our goal was to evaluate the influence of an extreme change in fructose while holding adiposity constant by careful focus on caloric and body weight control. One advantage of animal models, especially Old World monkeys with gastrointestinal tracts more comparable to humans, is sufficient longer-term environmental control to unmask perturbations induced by manipulation of nutritional variables. A potential next step would be to narrow the intake range over which health effects may be seen, while matching all dietary ingredients including protein source. Casein is known to be proatherogenic in the context of cholesterol-loaded dietary experiments (5); however, we actually reported no elevations in plasma or liver cholesterol concentrations (free or esterified) with high-fructose/casein diets, endpoints that are known risk factors for atherosclerosis (6). We therefore believe that the lack of differences seen in these endpoints in our study suggests that protein source did not primarily influence metabolic health, microbial translocation, and liver injury outcomes. We conclude that consumption of very high amounts of simple carbohydrate is likely to impair intestinal integrity and initiate liver and metabolic changes. Human and rodent studies involving exaggerated diets support the greater potency of fructose compared with glucose in initiation of such changes (3, 7), and future experiments should refine these findings using relevant diets in relevant animal studies.
Acknowledgments
None of the authors had any conflicts of interest with respect to the work presented.
REFERENCES
- 1.Kavanagh K, Wylie AT, Tucker KL, Hamp TJ, Gharaibeh RZ, Fodor AA, Cullen JM. Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates. Am J Clin Nutr 2013;98:349–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Marriott BP, Cole N, Lee E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr 2009;139:1228S–35S. [DOI] [PubMed] [Google Scholar]
- 3.Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009;119:1322–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bremer AA, Stanhope KL, Graham JL, Cummings BP, Wang W, Saville BR, Havel PJ. Fructose-fed rhesus monkeys: a nonhuman primate model of insulin resistance, metabolic syndrome, and type 2 diabetes. Clin Transl Sci 2011;4:243–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kritchevsky D, Davidson LM, Kim HK, Krendel DA, Malhotra S, Mendelsohn D, van der Watt JJ, duPlessis JP, Winter PA. Influence of type of carbohydrate on atherosclerosis in baboons fed semipurified diets plus 0.1% cholesterol. Am J Clin Nutr 1980;33:1869–87. [DOI] [PubMed] [Google Scholar]
- 6.Rudel LL, Haines J, Sawyer JK, Shah R, Wilson MS, Carr TP. Hepatic origin of cholesteryl oleate in coronary artery atherosclerosis in African green monkeys. Enrichment by dietary monounsaturated fat. J Clin Invest 1997;100:74–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Bergheim I, Weber S, Vos M, Krämer S, Volynets V, Kaserouni S, McClain CJ, Bischoff SC. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 2008;48:983–92. [DOI] [PubMed] [Google Scholar]